Alaunos Therapeutics, Inc. (TCRT) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts TCRT Hot Sheet
Join SI Premium – FREE
Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04).
For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
